GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹4.57 Cr | ₹74 Cr | ₹21 Cr | ₹-1.83 Cr | ₹1.62 Cr |
What is the latest Cash Flow from Financing Activities ratio of GENNEX LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹4.57 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹21 Cr |
| Mar2022 | ₹-1.83 Cr |
| Mar2021 | ₹1.62 Cr |
How is Cash Flow from Financing Activities of GENNEX LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.57 Cr | -93.80 | |
| Mar2024 | ₹74 Cr | 250.33 | |
| Mar2023 | ₹21 Cr | Positive | |
| Mar2022 | ₹-1.83 Cr | Negative | |
| Mar2021 | ₹1.62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹213.3 Cr | -3.3% | -16.9% | -32.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -3.3% |
-16.9% |
-32.9% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses